Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: Induction or Consolidation Chemotherapy?
- 10 August 2022
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 40 (23) , 2515-2519
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12Journal of Clinical Oncology, 2019
- Achieving a Complete Clinical Response After Neoadjuvant Chemoradiation That Does Not Require Surgical Resection: It May Take Longer Than You Think!Diseases of the Colon & Rectum, 2019
- Randomized clinical trial of short or long interval between neoadjuvant chemoradiotherapy and surgery for rectal cancerBritish Journal of Surgery, 2018
- Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal CancerJAMA Oncology, 2018
- Tailored Treatment Strategy for Locally Advanced Rectal Carcinoma Based on the Tumor Response to Induction Chemotherapy: Preliminary Results of the French Phase II Multicenter GRECCAR4 TrialDiseases of the Colon & Rectum, 2017
- A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysisThe Lancet Gastroenterology & Hepatology, 2017
- Results of a prospective randomised control 6 vs 12 trial: Is greater tumour downstaging observed on post treatment MRI if surgery is delayed to 12-weeks versus 6-weeks after completion of neoadjuvant chemoradiotherapy?Annals of Oncology, 2016
- Long-Term Results of RTOG 91-11: A Comparison of Three Nonsurgical Treatment Strategies to Preserve the Larynx in Patients With Locally Advanced Larynx CancerJournal of Clinical Oncology, 2013
- Neoadjuvant chemotherapy prior to preoperative chemoradiation or radiation in rectal cancer: should we be more cautious?British Journal of Cancer, 2006
- Value of radiation therapy in the management of chemoresistant intermediate grade non-Hodgkin's lymphomaRadiation Oncology Investigations, 1999